These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 37961996)

  • 1. New insights into the interaction between m6A modification and lncRNA in cancer drug resistance.
    Jin Y; Fan Z
    Cell Prolif; 2024 Apr; 57(4):e13578. PubMed ID: 37961996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutual regulation between N6-methyladenosine (m6A) modification and circular RNAs in cancer: impacts on therapeutic resistance.
    Lin H; Wang Y; Wang P; Long F; Wang T
    Mol Cancer; 2022 Jul; 21(1):148. PubMed ID: 35843942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N6-methyladenosine methylation analysis of long noncoding RNAs and mRNAs in 5-FU-resistant colon cancer cells.
    Lai J; Zhou Z; Hu K; Yu H; Su X; Niu X; Li H; Mao S
    Epigenetics; 2024 Dec; 19(1):2298058. PubMed ID: 38145548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N6-methyladenosine (m6A) in cancer therapeutic resistance: Potential mechanisms and clinical implications.
    Wang D; Zhang Y; Li Q; Zhang A; Xu J; Li Y; Li W; Tang L; Yang F; Meng J
    Biomed Pharmacother; 2023 Nov; 167():115477. PubMed ID: 37696088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The interplay between m6A modification and non-coding RNA in cancer stemness modulation: mechanisms, signaling pathways, and clinical implications.
    Qin S; Mao Y; Wang H; Duan Y; Zhao L
    Int J Biol Sci; 2021; 17(11):2718-2736. PubMed ID: 34345203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N6-methyladenosine links RNA metabolism to cancer progression.
    Dai D; Wang H; Zhu L; Jin H; Wang X
    Cell Death Dis; 2018 Jan; 9(2):124. PubMed ID: 29374143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel N6-methyladenosine (m6A)-dependent fate decision for the lncRNA THOR.
    Liu H; Xu Y; Yao B; Sui T; Lai L; Li Z
    Cell Death Dis; 2020 Aug; 11(8):613. PubMed ID: 32792482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N6-methyladenosine (m6A) modification in osteosarcoma: expression, function and interaction with noncoding RNAs - an updated review.
    Zhang Y; Xu Y; Bao Y; Luo Y; Qiu G; He M; Lu J; Xu J; Chen B; Wang Y
    Epigenetics; 2023 Dec; 18(1):2260213. PubMed ID: 37766615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KIAA1429 contributes to liver cancer progression through N6-methyladenosine-dependent post-transcriptional modification of GATA3.
    Lan T; Li H; Zhang D; Xu L; Liu H; Hao X; Yan X; Liao H; Chen X; Xie K; Li J; Liao M; Huang J; Yuan K; Zeng Y; Wu H
    Mol Cancer; 2019 Dec; 18(1):186. PubMed ID: 31856849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Examining the evidence for mutual modulation between m6A modification and circular RNAs: current knowledge and future prospects.
    Tang X; Guo M; Zhang Y; Lv J; Gu C; Yang Y
    J Exp Clin Cancer Res; 2024 Aug; 43(1):216. PubMed ID: 39095902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The interplay between m6A RNA methylation and noncoding RNA in cancer.
    Ma S; Chen C; Ji X; Liu J; Zhou Q; Wang G; Yuan W; Kan Q; Sun Z
    J Hematol Oncol; 2019 Nov; 12(1):121. PubMed ID: 31757221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exosome-shuttled FTO from BM-MSCs contributes to cancer malignancy and chemoresistance in acute myeloid leukemia by inducing m6A-demethylation: A nano-based investigation.
    Kou R; Li T; Fu C; Jiang D; Wang Y; Meng J; Zhong R; Liang C; Dong M
    Environ Res; 2024 Mar; 244():117783. PubMed ID: 38048862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction and validation of N6-methyladenosine long non-coding RNAs signature of prognostic value for early biochemical recurrence of prostate cancer.
    Liu J; Zhang W; Wang J; Lv Z; Xia H; Zhang Z; Zhang Y; Wang J
    J Cancer Res Clin Oncol; 2023 May; 149(5):1969-1983. PubMed ID: 35731271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surmounting cancer drug resistance: New insights from the perspective of N
    Li B; Jiang J; Assaraf YG; Xiao H; Chen ZS; Huang C
    Drug Resist Updat; 2020 Dec; 53():100720. PubMed ID: 32892147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel insight into the functions of N
    He Y; Du X; Chen M; Han L; Sun J
    Int J Oncol; 2022 Dec; 61(6):. PubMed ID: 36263625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New insights into the interplay between long non-coding RNAs and RNA-binding proteins in cancer.
    Yao ZT; Yang YM; Sun MM; He Y; Liao L; Chen KS; Li B
    Cancer Commun (Lond); 2022 Feb; 42(2):117-140. PubMed ID: 35019235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of m6A-Mediated DNA Damage Repair in Tumor Development and Chemoradiotherapy Resistance.
    Qu L; Liu SJ; Zhang L; Liu JF; Zhou YJ; Zeng PH; Jing QC; Yin WJ
    Cancer Control; 2024; 31():10732748241247170. PubMed ID: 38662732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SRSF3-mediated regulation of N6-methyladenosine modification-related lncRNA ANRIL splicing promotes resistance of pancreatic cancer to gemcitabine.
    Wang ZW; Pan JJ; Hu JF; Zhang JQ; Huang L; Huang Y; Liao CY; Yang C; Chen ZW; Wang YD; Shen BY; Tian YF; Chen S
    Cell Rep; 2022 May; 39(6):110813. PubMed ID: 35545048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N6-methyladenosine (m6A) in cancer stem cell: From molecular mechanisms to therapeutic implications.
    Wang L; Tang Y
    Biomed Pharmacother; 2023 Jul; 163():114846. PubMed ID: 37167725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel Insights Into the Role of N6-Methyladenosine RNA Modification in Bone Pathophysiology.
    Chen J; Tian Y; Zhang Q; Ren D; Zhang Q; Yan X; Wang L; He Z; Zhang W; Zhang T; Yuan X
    Stem Cells Dev; 2021 Jan; 30(1):17-28. PubMed ID: 33231507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.